202 related articles for article (PubMed ID: 3335964)
1. Pulmonary hypertension in infants with bronchopulmonary dysplasia.
Goodman G; Perkin RM; Anas NG; Sperling DR; Hicks DA; Rowen M
J Pediatr; 1988 Jan; 112(1):67-72. PubMed ID: 3335964
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia.
Abman SH; Wolfe RR; Accurso FJ; Koops BL; Bowman CM; Wiggins JW
Pediatrics; 1985 Jan; 75(1):80-4. PubMed ID: 3838113
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
Brownlee JR; Beekman RH; Rosenthal A
Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
[TBL] [Abstract][Full Text] [Related]
4. Effects of supplemental oxygen administration in an infant with pulmonary artery hypertension.
Palmisano JM; Martin JM; Krauzowicz BA; Truman KH; Meliones JN
Heart Lung; 1990 Nov; 19(6):627-30. PubMed ID: 2228653
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
Kasian GF; Ninan A; Duncan WJ; Bingham WT; Mersal A; Tyrrell MJ; Sankaran K
Can J Cardiol; 1988 May; 4(4):181-4. PubMed ID: 3395914
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in systemic lupus erythematosus: hemodynamics and effects of vasodilator therapy.
Santini D; Fox D; Kloner RA; Konstam M; Rude RE; Lorell BH
Clin Cardiol; 1980 Dec; 3(6):406-11. PubMed ID: 7460402
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.
Mourani PM; Abman SH
Clin Perinatol; 2015 Dec; 42(4):839-55. PubMed ID: 26593082
[TBL] [Abstract][Full Text] [Related]
8. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Dal Nogare AR; Rubin LJ
Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
[TBL] [Abstract][Full Text] [Related]
9. The pulmonary circulation in bronchopulmonary dysplasia.
Parker TA; Abman SH
Semin Neonatol; 2003 Feb; 8(1):51-61. PubMed ID: 12667830
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia.
Kao LC; Durand DJ; McCrea RC; Birch M; Powers RJ; Nickerson BG
J Pediatr; 1994 May; 124(5 Pt 1):772-81. PubMed ID: 8176568
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
McGoon MD; Seward JB; Vlietstra RE; Choo MH; Moyer TP; Reeder GS
Br Heart J; 1983 Dec; 50(6):579-85. PubMed ID: 6652000
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.
Johnson CE; Beekman RH; Kostyshak DA; Nguyen T; Oh DM; Amidon GL
Pediatr Res; 1991 May; 29(5):500-3. PubMed ID: 1896255
[TBL] [Abstract][Full Text] [Related]
13. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
Tuxen DV; Powles AC; Mathur PN; Pugsley SO; Campbell EJ
Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.
Beekman RH; Rocchini AP; Rosenthal A
Circulation; 1982 Mar; 65(3):523-8. PubMed ID: 6459891
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of bronchopulmonary dysplasia.
Berman W; Katz R; Yabek SM; Dillon T; Fripp RR; Papile LA
J Pediatr; 1986 Jul; 109(1):45-50. PubMed ID: 3755166
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.
Khemani E; McElhinney DB; Rhein L; Andrade O; Lacro RV; Thomas KC; Mullen MP
Pediatrics; 2007 Dec; 120(6):1260-9. PubMed ID: 18055675
[TBL] [Abstract][Full Text] [Related]
18. Severe pulmonary arterial hypertension in a very premature baby with bronchopulmonary dysplasia: normalization with long-term sildenafil.
Caputo S; Furcolo G; Rabuano R; Basilicata AM; Pilla LM; De Simone A; Pasquariello B; Ciampi Q; Vetrano G; Villari B
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):704-6. PubMed ID: 19829144
[TBL] [Abstract][Full Text] [Related]
19. Bronchopulmonary Dysplasia: When the Very Preterm Baby Comes Home.
Anderson C; Hillman NH
Mo Med; 2019; 116(2):117-122. PubMed ID: 31040497
[TBL] [Abstract][Full Text] [Related]
20. Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Piquet J; de Cremoux H; Lemaire F
Am Rev Respir Dis; 1987 Dec; 136(6):1343-9. PubMed ID: 3688636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
